CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy

doi:10.3390/pharmaceutics16030346

Article

CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy

1 Mar 2024

Abstract excerpt

Clustered regularly interspaced short palindromic repeat-associated protein Cas9 (CRISPR/Cas9) technology is at the forefront of cancer immunotherapy innovation, offering precise and personalized treatment strategies. In this review, we discuss CRISPR/Cas9's ability to precisely edit the genome, its impact on immune checkpoint control, and its application in immune cell engineering, where it surpasses traditional...

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.